Definition
什么是再生医疗?
再生医学关注组织修复、功能恢复、细胞治疗、外泌体研究、组织工程与再生科学。它不是单一项目,也不应被简化为抗衰服务。AETERA 将其放在医学证据、医生评估、机构标准、监管边界和长期随访中理解。


Medical Risk Statement
再生医疗是一个快速发展的领域,并非所有疗法都具有相同证据等级。适配性、风险、收益和监管因素会因患者、机构和司法辖区而异。任何医疗决策都应与合格医生讨论后作出。
Definition
再生医学关注组织修复、功能恢复、细胞治疗、外泌体研究、组织工程与再生科学。它不是单一项目,也不应被简化为抗衰服务。AETERA 将其放在医学证据、医生评估、机构标准、监管边界和长期随访中理解。
AETERA Position
面对再生医疗,应保持好奇、谨慎和基于信息的判断。AETERA 的角色不是推广治疗,而是帮助客户理解选择,并做出更好的长期健康决策。
Understand cell therapy concepts, suitability, regulatory documentation, and risk boundaries before considering any program.
Read more
Review extracellular vesicle and exosome discussions as a scientific field, not as a guaranteed treatment claim.
Read more
Place tissue repair, biomaterials, cells, and regenerative science inside an evidence and clinical-use framework.
Read more
Separate established practice, emerging applications, investigational studies, and early-stage concepts.
Read more
Review institution standards, physician responsibility, documentation, adverse-event planning, and jurisdictional rules.
Read more
Evidence
| Evidence Level | Description |
|---|---|
| Established Clinical Practice | Widely used within appropriate indications and supported by mature clinical standards. |
| Emerging Clinical Applications | Growing evidence, but suitability and standards still require careful physician assessment. |
| Investigational Research | Limited or study-specific evidence; should be understood through research design and consent. |
| Experimental Concepts | Early-stage ideas that should not be presented as routine care or guaranteed outcomes. |
Japan
日本有再生医疗相关法规框架,医疗机构需遵循相应监管要求。不同项目适用不同规则,是否适合需由医生判断。再生医疗的监管状态取决于具体程序、机构和适用法规。
Suitability
不一定。年龄、既往病史、诊断、治疗目标和医生评估都会影响适配性。AETERA 不预设再生医疗适合每一个人。
Decision Framework
Understand the objective
Review medical history
Assess available evidence
Evaluate institutional standards
Discuss risks and limitations
Coordinate information gathering
Support informed decision-making
Regenerative medicine is a field that studies tissue repair, functional recovery, cellular mechanisms, and regenerative science. It is not a single treatment or a guaranteed anti-aging solution.
Stem cell therapy refers to medical or research approaches that use cells or cell-related mechanisms. Suitability, evidence, cell source, processing standards, and regulatory documentation must be reviewed carefully.
Exosomes are extracellular vesicles involved in cell communication. They are widely discussed in research, but clinical claims require careful review of evidence, preparation standards, and applicable regulation.
No. Age, diagnosis, medical history, treatment goals, contraindications, and physician assessment all influence suitability.
Suitability is evaluated through medical history, current diagnosis, laboratory and imaging data, risk factors, goals, alternative options, and physician judgment.
Ask about evidence level, indication, expected benefit, risks, alternatives, physician credentials, institution standards, regulatory documents, follow-up, and adverse-event management.
Risks vary by procedure and patient. They may include infection, immune reaction, inappropriate indication, poor-quality preparation, uncertain benefit, delayed standard care, or inadequate follow-up.
Japan has regulatory frameworks related to regenerative medicine. The status of a specific procedure depends on the procedure, institution, physician responsibility, documentation, and applicable rules.
It should not be simplified that way. The regulatory status depends on the specific procedure, institution, and applicable regulations.
No. AETERA provides education, coordination, record preparation, and decision support. Medical advice, diagnosis, and treatment decisions must come from qualified physicians.
No. AETERA does not guarantee outcomes, reverse aging claims, cure claims, or suitability for any regenerative medicine option.
No. AETERA's role is not to promote treatments. Our role is to help clients understand options, risks, evidence, and decision pathways.
Relevant documents may include medical records, lab reports, imaging, medication history, consent forms, institution materials, physician background, regulatory documentation, and follow-up plans.
Evidence levels help clients distinguish mature clinical practice from emerging applications, investigational research, and early-stage concepts.
A Medical Family Office helps organize information, ask better questions, review risk boundaries, coordinate qualified opinions, and support long-term family health decisions.
AETERA helps families turn complex regenerative medicine information into a clearer, physician-led decision pathway.
申请私密顾问沟通